PMID- 38459065 OWN - NLM STAT- MEDLINE DCOM- 20240311 LR - 20240312 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 14 IP - 1 DP - 2024 Mar 8 TI - The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population. PG - 5749 LID - 10.1038/s41598-024-55313-0 [doi] LID - 5749 AB - The clinical utility of a type 2 diabetes mellitus (T2DM) polygenic risk score (PRS) in the East Asian population remains underexplored. We aimed to examine the potential prognostic value of a T2DM PRS and assess its viability as a clinical instrument. We first established a T2DM PRS for 5490 Korean individuals using East Asian Biobank data (269,487 samples). Subsequently, we assessed the predictive capability of this T2DM PRS in a prospective longitudinal study with baseline data and data from seven additional follow-ups. Our analysis showed that the T2DM PRS could predict the transition of glucose tolerance stages from normal glucose tolerance to prediabetes and from prediabetes to T2DM. Moreover, T2DM patients in the top-decile PRS group were more likely to be treated with insulin (hazard ratio = 1.69, p value = 2.31E-02) than were those in the remaining PRS groups. T2DM PRS values were significantly high in the severe diabetes subgroup, characterized by insulin resistance and beta -cell dysfunction (p value = 0.0012). The prediction models with the T2DM PRS had significantly greater Harrel's C-indices than did corresponding models without it. By utilizing prospective longitudinal study data and extensive clinical risk factor information, our analysis provides valuable insights into the multifaceted clinical utility of the T2DM PRS. CI - (c) 2024. The Author(s). FAU - Kim, Na Yeon AU - Kim NY AD - Graduate School of Data Science, Seoul National University, Seoul, South Korea. FAU - Lee, Haekyung AU - Lee H AD - Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, South Korea. FAU - Kim, Sehee AU - Kim S AD - Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, South Korea. FAU - Kim, Ye-Jee AU - Kim YJ AD - Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, South Korea. FAU - Lee, Hyunsuk AU - Lee H AD - Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. AD - Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea. AD - Genomic Medicine Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea. FAU - Lee, Junhyeong AU - Lee J AD - Graduate School of Data Science, Seoul National University, Seoul, South Korea. FAU - Kwak, Soo Heon AU - Kwak SH AD - Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. FAU - Lee, Seunggeun AU - Lee S AD - Graduate School of Data Science, Seoul National University, Seoul, South Korea. lee7801@snu.ac.kr. LA - eng GR - 2020H1D3A2A03100666/Brain Pool Plus (Brain Pool+) Program/ PT - Journal Article DEP - 20240308 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Blood Glucose) SB - IM MH - Humans MH - *Diabetes Mellitus, Type 2/epidemiology/genetics MH - *Prediabetic State/epidemiology/genetics MH - Prospective Studies MH - Genetic Risk Score MH - Clinical Relevance MH - Longitudinal Studies MH - Blood Glucose/analysis MH - Risk Factors MH - Republic of Korea/epidemiology PMC - PMC10923897 COIS- The authors declare no competing interests. EDAT- 2024/03/09 10:42 MHDA- 2024/03/11 06:43 PMCR- 2024/03/08 CRDT- 2024/03/08 23:21 PHST- 2023/05/30 00:00 [received] PHST- 2024/02/22 00:00 [accepted] PHST- 2024/03/11 06:43 [medline] PHST- 2024/03/09 10:42 [pubmed] PHST- 2024/03/08 23:21 [entrez] PHST- 2024/03/08 00:00 [pmc-release] AID - 10.1038/s41598-024-55313-0 [pii] AID - 55313 [pii] AID - 10.1038/s41598-024-55313-0 [doi] PST - epublish SO - Sci Rep. 2024 Mar 8;14(1):5749. doi: 10.1038/s41598-024-55313-0.